{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027748",
    "licUnit": "1",
    "validDate": "2029-12-03 00:00:00.000",
    "issueDate": "2019-12-03 00:00:00.000",
    "oriIssueDate": "2019-12-03",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202774801",
    "prodNameC": "維泰凱 膠囊100毫克",
    "prodNameE": "VITRAKVI 100mg capsule",
    "indicationsName": [
        "適用於有NTRK 基因融合的實體腫瘤之成人和兒童病人，並應符合以下三項條件:\r\n1、具NTRK基因融合且無已知的後天阻抗性突變(acquired resistance mutation)；\r\n2、為轉移性實體腫瘤，或手術切除極可能造成嚴重病症(severe morbidity)；\r\n3、沒有合適的替代治療選項，或於治療後發生疾病惡化。"
    ],
    "does": "1130",
    "packageUnit": [
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "HE"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": "A",
    "mainCategory": "A",
    "drBaseId": "81727913-04C5-47BB-B044-6C62CF66E169",
    "subCategory": [
        "A01"
    ],
    "ingredientsDesc": [
        "Larotrectinib"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1S 須執行確認性療效臨床試驗",
        "5F 免除銜接性試驗"
    ],
    "applicantName": "台灣拜耳股份有限公司",
    "applicantAddr": "台北市信義區信義路5段7號53樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2024-12-03",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "E416C701-4C3F-4975-8E31-C29599723105",
            "factoryCode": "1",
            "factoryName": "PENN PHARMACEUTICAL SERVICES LIMITED",
            "factoryAddr": "UNITS 23-24, TAFARNAUBACH INDUSTRIAL ESTATE, TAFARNAUBACH, TREDEGAR, NP22 3AA, UNITED KINGDOM",
            "factoryCompanyAddr": null,
            "countryCode": "GB",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FGB0225100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "718093F6-CDA5-4675-98B9-462BABCD9E75",
            "factoryCode": "2",
            "factoryName": "Orion Corporation",
            "factoryAddr": "Joensuunkatu 7, Salo 24100, Finland",
            "factoryCompanyAddr": null,
            "countryCode": "FI",
            "processCode": [
                {
                    "value": "02",
                    "name": "包裝"
                }
            ],
            "processCodeStr": "02;包裝",
            "factoryKind": "M",
            "factoryNo": "FFI0031000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013007500",
            "ingredientsName": "Larotrectinib",
            "ingredientsDesc": "Larotrectinib",
            "concentDesc": "(Equivalent to Larotrectinib sulfate......122.9mg)",
            "concent": "100.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EX12"
        }
    ],
    "licBaseId": "77ABF405-FA6B-4E51-9908-BD1C947AD8D3"
}